Viewing Study NCT00421018



Ignite Creation Date: 2024-05-05 @ 5:18 PM
Last Modification Date: 2024-10-26 @ 9:30 AM
Study NCT ID: NCT00421018
Status: COMPLETED
Last Update Posted: 2012-08-15
First Post: 2007-01-10

Brief Title: Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life NOAK
Sponsor: Karolinska Institutet
Organization: Karolinska Institutet

Study Overview

Official Title: Optimization of the Anti-Inflammatory Treatment of Asthma Patients Through Exhaled NO Measurements for Increased Asthma-Related Quality of Life in Primary Health Care NOAK
Status: COMPLETED
Status Verified Date: 2012-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine whether use of exhaled NO nitric oxide to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None